Literature DB >> 6707200

Glutathione redox cycle protects cultured endothelial cells against lysis by extracellularly generated hydrogen peroxide.

J M Harlan, J D Levine, K S Callahan, B R Schwartz, L A Harker.   

Abstract

We have examined the role of the glutathione redox cycle as an antioxidant defense mechanism in cultured bovine and human endothelial cells by disrupting the glutathione redox cycle at several points. Endothelial glutathione reductase was selectively inhibited with 1,3-bis(chloroethyl)-1-nitrosourea (BCNU). Cellular stores of reduced glutathione were depleted by reaction with diethylmaleate (DEM) or 1-chloro-2,4-dinitrobenzene (CDNB) or by inhibition of glutathione synthesis with buthionine sulfoximine (BSO). Whereas several strains of untreated bovine and human endothelial cells were resistant to lysis by enzymatically generated hydrogen peroxide, BCNU-treated cells were readily lysed in a time- and dose-dependent manner. Glucose-glucose oxidase-mediated lysis of BCNU-treated bovine endothelial cells was catalase-inhibitable and directly related to BCNU concentration and endogenous glutathione reductase activity. Pretreatment of bovine endothelial cells with BCNU did not potentiate lysis by distilled water, calcium ionophore, lipopolysaccharide, or hypochlorous acid. Depletion of cellular reduced glutathione by reaction with DEM or CDNB or by inhibition of glutathione synthesis by BSO also potentiated endothelial lysis by enzymatically generated hydrogen peroxide. Inhibition of endothelial glutathione reductase by BCNU or depletion of reduced glutathione by BSO increased endothelial susceptibility to lysis by hydrogen peroxide generated by phorbol myristate acetate-activated neutrophils. We conclude that the glutathione redox cycle plays an important role as an endogenous antioxidant defense mechanism in cultured endothelial cells.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6707200      PMCID: PMC425072          DOI: 10.1172/JCI111263

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  26 in total

1.  Oxygen radicals mediate endothelial cell damage by complement-stimulated granulocytes. An in vitro model of immune vascular damage.

Authors:  T Sacks; C F Moldow; P R Craddock; T K Bowers; H S Jacob
Journal:  J Clin Invest       Date:  1978-05       Impact factor: 14.808

2.  Severe generalized glutathione reductase deficiency after antitumor chemotherapy with BCNU" [1,3-bis(chloroethyl)-1-nitrosourea].

Authors:  H Frischer; T Ahmad
Journal:  J Lab Clin Med       Date:  1977-05

3.  Isolation of mononuclear cells and granulocytes from human blood. Isolation of monuclear cells by one centrifugation, and of granulocytes by combining centrifugation and sedimentation at 1 g.

Authors:  A Böyum
Journal:  Scand J Clin Lab Invest Suppl       Date:  1968

4.  Abnormalities of the hexose monophosphate shunt.

Authors:  E Beutler
Journal:  Semin Hematol       Date:  1971-10       Impact factor: 3.851

5.  Selection and characterization of bovine aortic endothelial cells.

Authors:  S M Schwartz
Journal:  In Vitro       Date:  1978-12

6.  Studies on the chlorinating activity of myeloperoxidase.

Authors:  J E Harrison; J Schultz
Journal:  J Biol Chem       Date:  1976-03-10       Impact factor: 5.157

7.  Effect of phagocytosis on the reduced soluble sulfhydryl content of human granulocytes.

Authors:  D S Mendelson; E N Metz; A L Sagone
Journal:  Blood       Date:  1977-12       Impact factor: 22.113

8.  Glutathione-dependent peroxidative metabolism in the alveolar macrophage.

Authors:  M T Vogt; C Thomas; C L Vassallo; R E Basford; J B Gee
Journal:  J Clin Invest       Date:  1971-02       Impact factor: 14.808

9.  Inactivation of glutathione reductase by 2-chloroethyl nitrosourea-derived isocyanates.

Authors:  J R Babson; D J Reed
Journal:  Biochem Biophys Res Commun       Date:  1978-07-28       Impact factor: 3.575

10.  Factors influencing endothelial cell proliferation in vitro.

Authors:  R T Wall; L A Harker; L J Quadracci; G E Striker
Journal:  J Cell Physiol       Date:  1978-08       Impact factor: 6.384

View more
  63 in total

Review 1.  Hsp90 inhibitors and drug resistance in cancer: the potential benefits of combination therapies of Hsp90 inhibitors and other anti-cancer drugs.

Authors:  Xiangyi Lu; Li Xiao; Luan Wang; Douglas M Ruden
Journal:  Biochem Pharmacol       Date:  2011-11-22       Impact factor: 5.858

2.  Effect of propionyl-L-carnitine on human endothelial cells.

Authors:  V W van Hinsbergh; M A Scheffer
Journal:  Cardiovasc Drugs Ther       Date:  1991-02       Impact factor: 3.727

3.  Effects of tumor-necrosis-factor-activated neutrophils on tumor cell survival.

Authors:  H Shau
Journal:  Immunol Res       Date:  1991       Impact factor: 2.829

4.  Injury to endothelial cells by phagocytosing polymorphonuclear leukocytes and modulatory role of lipoxygenase products.

Authors:  C M Vandenbroucke-Grauls; H M Thijssen; K P van Kessel; B S van Asbeck; J Verhoef
Journal:  Infect Immun       Date:  1987-06       Impact factor: 3.441

5.  Ceruloplasmin reduces the adhesion and scavenges superoxide during the interaction of activated polymorphonuclear leukocytes with endothelial cells.

Authors:  C Broadley; R L Hoover
Journal:  Am J Pathol       Date:  1989-10       Impact factor: 4.307

6.  Walker carcinosarcoma cells damage endothelial cells by the generation of reactive oxygen species.

Authors:  S G Shaughnessy; M R Buchanan; S Turple; M Richardson; F W Orr
Journal:  Am J Pathol       Date:  1989-04       Impact factor: 4.307

7.  Human vascular smooth muscle cells and endothelial cells lack catalase activity and are susceptible to hydrogen peroxide.

Authors:  M Shingu; K Yoshioka; M Nobunaga; K Yoshida
Journal:  Inflammation       Date:  1985-09       Impact factor: 4.092

8.  Cellular mechanism of U78517F in the protection of porcine coronary artery endothelial cells from oxygen radical-induced damage.

Authors:  K Maeda; M Kimura; S Hayashi
Journal:  Br J Pharmacol       Date:  1993-04       Impact factor: 8.739

9.  Glutamine preserves liver glutathione after lethal hepatic injury.

Authors:  R W Hong; J D Rounds; W S Helton; M K Robinson; D W Wilmore
Journal:  Ann Surg       Date:  1992-02       Impact factor: 12.969

10.  Augmentation of glutathione in the fluid lining the epithelium of the lower respiratory tract by directly administering glutathione aerosol.

Authors:  R Buhl; C Vogelmeier; M Critenden; R C Hubbard; R F Hoyt; E M Wilson; A M Cantin; R G Crystal
Journal:  Proc Natl Acad Sci U S A       Date:  1990-06       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.